Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05552144 · ClinicalTrials.gov registry record

Documenting Toothbrushing Experiences of Caregivers Who Care for Children With Autism Spectrum Disorders

A clinical trial, sponsored by Colgate Palmolive.

Completed
Registry status
17
Enrollment target

NCT05552144: Completed study, sponsored by Colgate Palmolive.

NCT05552144 is a clinical trial that has completed, run by Colgate Palmolive. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05552144 has completed, sponsored by Colgate Palmolive.

COMPLETED
Registry status
17 participants
Enrollment target

Study Summary

The objective of this study is to examine caregiver reactions to the use of the hum by Colgate Smart Kids Toothbrush and associated app by children with autism spectrum disorder (ASD).

Primary Outcome

The hum Smart Kids Toothbrush aims to capture the reactions of the caregivers of the children with ASD on the ease and usefulness of the toothbrush and the app. The goal is to gauge if the experience of using the connected toothbrush is ultimately enjoyable for the caregivers of the children with ASD. Insights from the caregivers will assist in exploring the value of utilizing "smart" toothbrush technologies for oral hygiene in children with ASD.

Interventions

  • DEVICE Hum by Colgate Smart Kids Toothbrush (battery powered) - 490000006871

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2022-08-23
Est. Completion 2022-11-08
Colgate Palmolive

51 total trials

What the finished NCT05552144 record still lists

NCT05552144 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Hum by Colgate Smart Kids Toothbrush (battery powered) - 490000006871 is the first listed.

NCT05552144 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05552144 about?

NCT05552144 is a clinical study titled "Documenting Toothbrushing Experiences of Caregivers Who Care for Children With Autism Spectrum Disorders". The objective of this study is to examine caregiver reactions to the use of the hum by Colgate Smart Kids Toothbrush and associated app by children with autism spectrum disorder (ASD).

What is the current status of trial NCT05552144?

This trial is currently completed. The enrollment target is 17 participants. The study started on 2022-08-23. Estimated completion is 2022-11-08.

What interventions are being tested in trial NCT05552144?

The interventions under investigation include: Hum by Colgate Smart Kids Toothbrush (battery powered) - 490000006871 (DEVICE).

Who is sponsoring clinical trial NCT05552144?

This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05552144, the US trial registry maintained by the National Library of Medicine. NCT05552144 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.